A Study on Assessment of Clinical, Radiological Parameters in Women Suffering from PCOD
DOI:
https://doi.org/10.21276/dwy2rp53Keywords:
Polycystic ovary syndrome, endocrinological, Menstrual irregularitiesAbstract
Background: PCOS patients who fail to respond to CC are considered as clomiphene resistant. Approximately 15%–40% of women with PCOS, it is very common. Obesity, insulin resistance, ( 50%–70% of females with PCOS) and hyperandrogenemia are some major factors which postulated for CC resistance.
Methods: In this study 50 females were included on the basis of inclusion and exclusion criteria. The duration of study was over a period of 3 month. This study was conducted in the Department of Gynecology, K M Medical College & Hospital, Mathura
Result: This result revealed that 56% cases had elevated LH, 36% had hypothyroidism followed by 16% hyperprolactinemia & 4% hypoprolactinemia.
Conclusion: This study suggested that, Obesity and overweight are the most important modifiable risk factor which causes 70% of cases to prevent PCOS, weight reduction is one of the most important step.
Downloads
References
Rotterda ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007;370:685-97.
Atiomo WU, El-Mahdi E, Hardiman P. Familial associations in women with polycystic ovary syndrome. Fertil Steril2003;80:143-5.
Radosh L. Drug treatments for polycystic ovary syndrome. Am Fam Physician 2009;79:671-6.
National Institute for Health and Clinical Excellence: Guidance. In: Fertility: Assessment and Treatment for People with Fertility Problems. London (UK): National Institute for Health and Clinical Excellence: Guidance; 2004.
Parsanezhad ME, Alborzi S, Zarei A, Dehbashi S, Omrani G. Insulin resistance in clomiphene responders and non-responders with polycystic ovarian disease and therapeutic effects of metformin. Int J Gynaecol Obstet 2001;75:43-50.
Overbeek A, Kuijper EA, Hendriks ML, Blankenstein MA, Ketel IJ, Twisk JW, et al. Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome. Hum Reprod2009;24:2007-13.
Sohrevardi SM, Nosouhi F, Hossein Khalilzade S, Kafaie P, Karimi-Zarchi M, Halvaei I, et al. Evaluating the effect of insulin sensitizers metformin and pioglitazone alone and in combination on women with polycystic ovary syndrome: An RCT. Int J Reprod Biomed (Yazd) 2016;14:743-54.
Ayaz A, Alwan Y, Farooq MU. Metformin-clomiphene citrate vs. clomiphene citrate alone: Polycystic ovarian syndrome. J Hum Reprod Sci 2013;6:15-8.
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: The complete task force report. Fertil Steril 2009;91:456-88.
Balen A, Conway G, Klatas G et al. Polycystics ovary syndrome: the spectrum of the disorder in 1741 patients. Human Reproduction 1995; 10: 2107 - 2111.
Franks ,S.Adams J & Polson DW Prevalence of Polycystics Ovaries in women with anovulation and idiopathic hirsutism. BMJ 1986; 293: 355-359.
Turhan NO, Toppare MF, Seckin NC, Dilmen G. The predictive power of endocrine tests for the diagnosis of polycystic ovaries in women with oligoamenorrhea. Gynecol Obstet Invest 1999;48:183–6.
Aarti Sharma and William Atiomo. Recent development in polycystic ovary syndrome. Current Obstetrics & Gynaecology (2003) 13, 281 – 286.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.
